![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)
Nephros (OTC:NEPH): Three FDA Decisions, One Company
Michael Vlaicu (June 17th, 2009) Writes:
Nephros, Inc.
(OTC: NEPH)
A reader of StocksHaven Investments by the name of Michael Sklar has contributed the following article regarding Nephros, Inc. The article outlines one of the most undervalued BioPharma companies around, at only $1.08 PPS with three pending FDA decisions. If you are an avid investor of pre-PDUFA companies, StocksHaven Investments highly suggests you conduct some due diligence on this company, as its potential value greatly outweighs the risks involved. About: Nephros, Inc. (Nephros) is engaged primarily in the development of hemodiafiltration (HDF), products and technologies for treating patients with end stage renal disease (ESRD). The Company has three products in various stages of development in the HDF modality to deliver therapy to ESRD patients: OLpur MDHDF filter series (which it sells in various countries in Europe and consists of its MD190 and MD220 diafilters);
...American Hospital Association;, cholera, dialysis, director, disease prevention issues, DSU, DSU technology, e-coli, end stage renal disease, ESRD, Europe, Fda, filter technologies, filter technology, HD190, HDF, hemodiafiltration, hemodialysis, hepatitis, HIV, immune systems, industrial and retail opportunities, Market Commentary, MD190, Michael Sklar, Michael Vlaicu;, Mid-Dilution Diafiltration technology, Mid-Dilution filter, Mid-Dilution filter technologies, Nephros Inc., Office of Naval Research, Office of U.S. Naval Research, OLpur HD 190, OLpur HD190, OLpur MD, PMA Supplement, rubber gloves;, similar device, Stocks to Watch, StocksHaven Investments;, substantial infection, treatment devices;, U.S. Defense Department, U.S. Food and Drug Administration, United States, United States Marine Corps;, USD, Water
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.